Amsino Healthcare (USA) Inc.

Form 483 issued September 20, 2021 · Vernon Hills, Illinois

Inspection
Sep 7 – Sep 20, 2021
Observations
10
Pages
13
FEI number
1417519

In short: On September 20, 2021, FDA issued a Form 483 with 10 observations to Amsino Healthcare (USA) Inc. in Vernon Hills, Illinois (FEI 1417519) after an inspection that ran Sep 7 – Sep 20, 2021. The investigator was Michele L. Glendenning. Most observations concern facilities & equipment and cAPA; the most-cited regulation is 21 CFR 211.67 (equipment cleaning and maintenance).

At a glance

Observations span 4 systems, led by facilities & equipment.

Facilities & equipment3
CAPA2
Quality system2
Production & process controls1
Other2

What FDA observed

Preview: the opening words of each observation
  1. 01

    A process whose results cannot be fully verified by subsequent inspection and test has not been…

  2. 02

    Procedures for corrective and preventive action have…

  3. 03

    Corrective and preventive action activities and/or results have not…

  4. 04

    No management representative had been appointed to ensure that quality system requirements are met, and to…

6 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Amsino Healthcare (USA) Inc.?

FDA listed 10 observations on this Form 483, mostly about facilities & equipment, cAPA and quality system. The most-cited regulation is 21 CFR 211.67 (equipment cleaning and maintenance). The opening words of each observation are shown on this page.

Who inspected Amsino Healthcare (USA) Inc.?

Michele L. Glendenning is named on this Form 483, for the inspection of Sep 7 – Sep 20, 2021. Each investigator has a profile showing what they cite most.

When was Amsino Healthcare (USA) Inc. inspected by FDA?

The inspection ran Sep 7 – Sep 20, 2021, and the Form 483 is dated September 20, 2021.

How do I get the full Form 483 for Amsino Healthcare (USA) Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free